R S Benjamin
Overview
Explore the profile of R S Benjamin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
258
Citations
3679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valenzuela R, Duran-Sierra E, Canjirathinkal M, Amini B, Torres K, Benjamin R, et al.
Sci Rep
. 2024 Sep;
14(1):21681.
PMID: 39289469
Undifferentiated pleomorphic sarcoma (UPS) is the largest subgroup of soft tissue sarcomas. This study determined the value of perfusion-weighted imaging with dynamic-contrast-enhancement (PWI/DCE) morphologic, qualitative, and semiquantitative features for predicting...
2.
Livingston J, Bugano D, Barbo A, Lin H, Madewell J, Wang W, et al.
Sci Rep
. 2017 Sep;
7(1):11836.
PMID: 28928422
Benefit from chemotherapy for well-differentiated/de-differentiated (WD/DD) liposarcomas has been reported to be minimal, however traditional response criteria may not adequately capture positive treatment effect. In this study, we evaluate benefit...
3.
Bellera C, Penel N, Ouali M, Bonvalot S, Casali P, Nielsen O, et al.
Ann Oncol
. 2014 Jul;
26(5):865-872.
PMID: 25070543
Background: The use of potential surrogate end points for overall survival, such as disease-free survival (DFS) or time-to-treatment failure (TTF) is increasingly common in randomized controlled trials (RCTs) in cancer....
4.
Agulnik M, Yarber J, Okuno S, von Mehren M, Jovanovic B, Brockstein B, et al.
Ann Oncol
. 2012 Aug;
24(1):257-63.
PMID: 22910841
Background: To determine efficacy and safety of bevacizumab, a recombinant humanized antibody against vascular endothelial growth factor (VEGF), in the treatment of metastatic or locally advanced angiosarcoma and epithelioid hemangioendotheliomas....
5.
Pandurengan R, Dumont A, Araujo D, Ludwig J, Ravi V, Patel S, et al.
Ann Oncol
. 2010 Mar;
21(10):2107-2111.
PMID: 20348145
Background: We sought to investigate the characteristics and survival rate of patients with gastrointestinal stromal tumor (GIST) associated with other primary malignancies. Patients And Methods: A total of 783 patients...
6.
Subbiah V, Madsen V, Raymond A, Benjamin R, Ludwig J
Osteoporos Int
. 2009 Jul;
21(6):1041-5.
PMID: 19597911
Summary: Since approval by the U.S. Food and Drug Administration (FDA) in December 2002, teriparatide (recombinant 1-34 PTH; Forteo) has been safely used by more than 430,000 patients. Prior to...
7.
Trent II 2nd J, Benjamin R, Valero V
Curr Treat Options Oncol
. 2002 Jun;
2(2):169-76.
PMID: 12057135
Primary soft tissue sarcoma (STS) of the breast is a rare and heterogeneous disease. The rarity of this tumor limits most studies to small retrospective case reviews and case reports....
8.
Cormier J, Patel S, Herzog C, Ballo M, Burgess M, Feig B, et al.
Cancer
. 2001 Dec;
92(6):1550-5.
PMID: 11745234
Background: The current study was performed to evaluate the toxicity profile of therapeutic doses of ifosfamide (IFX) given concurrently with full-dose external beam radiotherapy (EBRT) in patients with soft tissue...
9.
Patel S, Jenkins J, Papadopolous N, Burgess M, Plager C, Gutterman J, et al.
Cancer
. 2001 Sep;
92(5):1347-8.
PMID: 11571751
No abstract available.
10.
Callister M, Ballo M, Pisters P, Patel S, Feig B, Pollock R, et al.
Int J Radiat Oncol Biol Phys
. 2001 Sep;
51(2):384-91.
PMID: 11567812
Purpose: To determine the outcome and prognostic factors for patients with localized epithelioid sarcoma treated with conservative surgery and radiotherapy (RT). Methods And Materials: The medical records of 24 patients...